CUSHINGS SYNDROME MARKET ANALYSIS

Cushings Syndrome MarketSize and Trends

Hormonal disorder caused due to prolonged exposure of body’s tissue to high levels of hormone cortisol leads to Cushing’s syndrome, also called hypercortisolism. Adults aged in the age group of 20-50 years suffer from Cushing’s syndrome. It is rarely seen, though has risk of development in patient who are obese and also have type 2 diabetes, high blood pressure with poorly controlled blood glucose. Cushing’s syndrome market is projected to increase due to rise in its awareness and healthcare expenditure. Various new drugs are available in market due to increase in research and development such as ketoconazole, metyrapone and mitotane to minimize the surgical risk of patient. According to Orphanet Journal of Rare Disease, incidence of Cushing’s syndrome is estimated to be equal to 1–3 cases per million inhabitants per year, whereas its prevalence is close to 40 cases per million inhabitants in 2012.